These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10525725)

  • 1. What can we learn from bone biology for the treatment for osteoporosis?
    Mundy GR
    Osteoporos Int; 1999; 9 Suppl 2():S40-7. PubMed ID: 10525725
    [No Abstract]   [Full Text] [Related]  

  • 2. New anabolic therapies in osteoporosis.
    Rubin MR; Bilezikian JP
    Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular and clinical parameters of anabolic therapy for osteoporosis.
    Rosen CJ
    Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.
    Debiais F
    Joint Bone Spine; 2003 Dec; 70(6):465-70. PubMed ID: 14667554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoprotegerin/RANKL/RANK system and postmenopausal osteoporosis. The possible therapeutic aspects].
    Kapczuk K; Sowińska-Przepiera E; Friebe Z
    Ginekol Pol; 2003 Apr; 74(4):323-31. PubMed ID: 12916277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring aging bones.
    Rosen CJ
    Sci Am; 2003 Mar; 288(3):70-7. PubMed ID: 12616861
    [No Abstract]   [Full Text] [Related]  

  • 7. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF; Morley P
    Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of bone loss and gain in untreated and treated osteoporosis.
    Compston J
    Endocrine; 2002 Feb; 17(1):21-7. PubMed ID: 12014699
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteoporosis from the point of view of the clinical endocrinologist.
    Szũcs J
    Agents Actions; 1994 Mar; 41(1-2):80-3. PubMed ID: 8079825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
    Tsai KS; Ebeling PR; Riggs BL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro.
    Schiavi J; Fodera DM; Brennan MA; McNamara LM
    Exp Cell Res; 2021 Nov; 408(1):112814. PubMed ID: 34492267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What to use to treat osteoporosis?].
    Välimäki MJ
    Duodecim; 2003; 119(24):2409-12. PubMed ID: 14870501
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of osteoporosis: role of bone-forming agents.
    Reginster JY; Halkin V; Henrotin Y; Gosset C
    Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
    [No Abstract]   [Full Text] [Related]  

  • 15. New concepts in bone metabolism: clinical implications.
    Mundy GR
    Hosp Pract (Off Ed); 1991; 26 Suppl 1():7-12. PubMed ID: 1898515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
    Ueland T; Bollerslev J; Mosekilde L
    Ugeskr Laeger; 2002 Jul; 164(27):3526-30. PubMed ID: 12116680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of fluorides in the treatment of postmenopausal osteoporosis].
    Mosekilde L
    Ugeskr Laeger; 2001 Aug; 163(32):4172-4. PubMed ID: 11510231
    [No Abstract]   [Full Text] [Related]  

  • 19. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
    Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstructing the skeleton with intermittent parathyroid hormone.
    Seeman E; Delmas PD
    Trends Endocrinol Metab; 2001 Sep; 12(7):281-3. PubMed ID: 11504661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.